AB Science Shares Up 3.69% Contrary to a Declining CAC 40
AB Science stands out with a notable increase this Thursday morning, as its shares rise by 3.69% to 1.236 euros after closing at 1.19 euros the previous day. This rebound occurs as the CAC 40 drops by 0.71% during the session, and the French biotech company has seen a nearly 16% decline over the past three months.
A Significant Uptick for AB Science
This morning, AB Science's shares are showing their first significant upward movement in several sessions, following a week with a modest gain of 1.48%. However, this rebound should be viewed in a broader context: over the year, the stock has fallen by 4.92%, while its quarterly performance shows a decline of 15.8%. The European pharmaceutical sector is mixed this Thursday, with Sanofi up by 0.36% while UCB is down by 0.97%.
Technical Analysis of the Stock
Graphically, the price of 1.236 euros is now in the upper part of the Bollinger Bands, at 68% of the range formed by the lower boundary at 1.12 euros and the upper boundary at 1.29 euros. Crossing this upper boundary during the session is a signal to watch: maintaining above 1.29 euros could pave the way towards the resistance identified at 1.36 euros, whereas a pullback would bring the stock back into its recent consolidation zone. The RSI, at 44, indicates a still moderate momentum, far from overbought zones. Both the 50-day and 200-day moving averages converge around 1.29 euros, a level the stock is precisely trying to reclaim this morning. The gap between the price and these averages remains small, indicating that the trend has not yet clearly turned upwards despite today's acceleration.
